MEDVi vs. NovoCare Pharmacy (Wegovy): prices, fine print, and the honest verdict

Tirzepatide pricing

MEDVi: $399 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $249/mo (12-month plan). NovoCare Pharmacy (Wegovy) routes patients to brand-name medication (Wegovy injectable (all doses $349), Wegovy HD 7.2 mg ($399), Wegovy oral tablets ($149 intro)): your medication cost is the manufacturer's self-pay rate (Zepbound $299–$449, Wegovy $349) or an insurance copay, plus any program fee.

Semaglutide pricing

On semaglutide, MEDVi wins at $299 versus $349 all-in — $50/mo apart. MEDVi: Semaglutide runs $299 a month all-in at the standing rate ($179 on intro/plan terms). NovoCare Pharmacy (Wegovy): Semaglutide runs $349 a month all-in at the standing rate ($199 on intro/plan terms).

Different products, not just different prices

NovoCare Pharmacy (Wegovy) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while MEDVi sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

MEDVi: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. NovoCare Pharmacy (Wegovy): Source-verified (verified 2026-08-09); names its pharmacy — Novo Nordisk direct / retail partners. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

MEDVi: 12-month plan for the lowest rate; 12-month plan applies to lowest rate. NovoCare Pharmacy (Wegovy): none; no subscription.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: MEDVi holds $399 on every rung (four-month titration: exactly $1,596). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

On semaglutide, MEDVi prices at $299 against $349 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. MEDVi's ranked figure is $399, with no membership to add; NovoCare Pharmacy (Wegovy) bills at manufacturer/insurance rates plus any stated program fee. 2 · Maintenance basis. MEDVi is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. MEDVi: standing $399, prepaid $249 effective (12-month plan) — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. MEDVi: source-verified, read 2026-08-05; NovoCare Pharmacy (Wegovy): source-verified, read 2026-08-09. 5 · Pharmacy weighed. MEDVi names no pharmacy; NovoCare Pharmacy (Wegovy) names Novo Nordisk direct / retail partners — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

MEDVi: no membership — the medication figure is the billed figure; prepaid 12-month plan at $249/mo effective; 12-month plan applies to lowest rate; commitment: 12-month plan for the lowest rate. NovoCare Pharmacy (Wegovy): no membership — the medication figure is the billed figure; no subscription; commitment: none. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

MEDVi carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. NovoCare Pharmacy (Wegovy) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Novo Nordisk direct / retail partners, manufacturer direct. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a MEDVi-to-NovoCare Pharmacy (Wegovy) move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: MEDVi: shipping included; consultation included; async visit model. NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); consultation bring your own prescription; prescription required visit model; savings-card pickup at 70,000+ retail pharmacies as the mail-order alternative. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick MEDVi if the semaglutide line is cheaper here; you want a price that survives titration; you'll prepay for the $249 effective rate. Pick NovoCare Pharmacy (Wegovy) if a named pharmacy is non-negotiable for you; only the FDA-approved product will do. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Remedy Meds at $399 (flat, no membership); Eden at $408 (dose-scaled, $99 membership included); Fridays at $359 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.